Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
The FDA has granted traditional approval for acalabrutinib to be used as a single agent in adults who have previously been treated for Mantle-Cell Lymphoma (MCL). In 2017, acalabrutinib received accelerated approval for this indication.
AACR FDA Approval Alert 01/17/25
…